Pa Shun International Holdings Limited (HKG:0574)
Hong Kong
· Delayed Price · Currency is HKD 0.0300
-0.0070 (-18.92%)
May 2, 2025, 4:08 PM HKT
HKG:0574 Revenue
In the year 2024, Pa Shun International Holdings had annual revenue of 86.55M CNY, down -33.13%. Pa Shun International Holdings had revenue of 48.83M in the half year ending June 30, 2024, with 46.25% growth.
Revenue
86.55M CNY
Revenue Growth
-33.13%
P/S Ratio
0.48
Revenue / Employee
961.71K CNY
Employees
90
Market Cap
44.25M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 86.55M | -42.88M | -33.13% |
| Dec 31, 2023 | 129.43M | 57.65M | 80.30% |
| Dec 31, 2022 | 71.78M | -14.13M | -16.45% |
| Dec 31, 2021 | 85.91M | -388.92M | -81.91% |
| Dec 31, 2020 | 474.84M | -370.61M | -43.84% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Innovent Biologics | 10.03B |
| Alibaba Health Information Technology | 31.39B |
| Akeso | 2.26B |
| Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |